Profiel
Andrew Marsh worked as the Head of Clinical Development at Ra Pharmaceuticals, Inc. and later as the Head of Development Operations at Synlogic, Inc. He completed his undergraduate degree at Boston University.
Eerdere bekende functies van Andrew Marsh
| Bedrijven | Functie | Einde |
|---|---|---|
| SYNLOGIC, INC. | Corporate Officer/Principal | 01-05-2021 |
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van Andrew Marsh
| Boston University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SYNLOGIC, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
